Phase 1b clinical trial assessing Tune-401 designed to treat chronic hepatitis B (CHB)
Latest Information Update: 15 Jan 2025
Price :
$35 *
At a glance
- Drugs TUNE-401 (Primary)
- Indications Hepatitis B
- Focus Adverse reactions
- 13 Jan 2025 According to Tune Therapeutics media release, Dr. Man-Fung Yuen is a Principal Investigator of this study.
- 13 Jan 2025 According to Tune Therapeutics media release, the company has received the approval to begin this study.
- 13 Jan 2025 New trial record